Clinical Trial Update: Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating photodynamic therapy using aminolevulinic acid for non-melanoma skin cancer. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Aminolevulinic acid (Levulan) (aminolevulinic acid)

Snippet

Sponsor: Laser and Skin Surgery Center of New York | Conditions: Non-melanomatous Skin Cancer | Phase 2 | Status: UNKNOWN